Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphoma
- PMID: 646924
- PMCID: PMC2009565
- DOI: 10.1038/bjc.1978.80
Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphoma
Abstract
To substantiate the origin of follicular (nodular) lymphoma cells from germinal-centre cells, the lymphoma cells from 7 patients with follicular lymphoma and from 9 tonsils and 2 lymph nodes were studied for the presence and distribution of complement-receptor subtypes (i.e., the receptors for C3b and C3d). It was found that erythrocytes coated with antibodies and C3d (EAC3d) adhered exclusively to germinal centres, whereas erythrocytes coated with antibodies and C3b (EAC3b) adhered to germinal centres and in many instances to the regions between them. These findings indicate that germinal-centre cells bear both complement-receptor subtypes and that the B cells of the interfollicular area, which belong at least in part to the precursors of plasma cells, bear only a receptor for C3b. In frozen sections of follicular lymphomas, a similar distribution of complement-receptor subtypes was observed; EAC3d was bound exclusively to the neoplastic nodules, and EAC3b adhered to the neoplastic nodules and adjacent paranodular tissue. Receptor studies on suspended cells of both normal tonsils and follicular lymphomas revealed a slight predominance of EAC3d(+) cells or equal numbers of EAC3b(+) and EAC3d(+) cells. The complete congruence in the expression and distribution of complement-receptor subtypes between tissues from follicular lymphomas and those from normal and hyperplastic tonsils or lymph nodes suggests that follicular lymphoma represents the neoplastic counterpart of the reactive germinal centre.
Similar articles
-
Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).Br J Cancer. 1980 Feb;41(2):168-82. doi: 10.1038/bjc.1980.27. Br J Cancer. 1980. PMID: 7370158 Free PMC article.
-
Complement receptor expression by neoplastic and normal human cells.J Immunol. 1983 Aug;131(2):899-905. J Immunol. 1983. PMID: 6306108
-
The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.Br J Cancer. 1983 Mar;47(3):327-51. doi: 10.1038/bjc.1983.52. Br J Cancer. 1983. PMID: 6338896 Free PMC article.
-
Complement (C3) receptors on dendritic reticulum cells of normal and malignant lymphoid tissue.Clin Exp Immunol. 1982 May;48(2):348-52. Clin Exp Immunol. 1982. PMID: 7049451 Free PMC article.
-
Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin.Blood. 1981 Jul;58(1):20-6. Blood. 1981. PMID: 6972240
Cited by
-
Follicular malignant non-Hodgkin's lymphoma with pronounced plasmacytic differentiation: a plasmacytoma-like lymphoma.Virchows Arch A Pathol Anat Histopathol. 1985;405(4):473-81. doi: 10.1007/BF00737173. Virchows Arch A Pathol Anat Histopathol. 1985. PMID: 3920819
-
Enzymic assay of C3b receptor on intact cells and solubilized cells.Biochem J. 1983 Feb 15;210(2):567-76. doi: 10.1042/bj2100567. Biochem J. 1983. PMID: 6222733 Free PMC article.
-
Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.Br J Cancer. 1980 Aug;42(2):224-42. doi: 10.1038/bjc.1980.222. Br J Cancer. 1980. PMID: 6775656 Free PMC article.
-
Demonstration of C3 receptors on frozen sections of normal lymphoid tissue and malignant lymphomas using various EAC complexes.Blut. 1980 Aug;41(2):101-18. doi: 10.1007/BF01039654. Blut. 1980. PMID: 7437525 No abstract available.
-
Hodgkin's disease: establishment and characterization of four in vitro cell lies.J Cancer Res Clin Oncol. 1981;101(1):111-24. doi: 10.1007/BF00405072. J Cancer Res Clin Oncol. 1981. PMID: 7276066 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources